Cargando…

Enhancement of DNA Vaccine-induced Immune Responses by Influenza Virus NP Gene

DNA immunization induces B and T cell responses to various pathogens and tumors. However, these responses are known to be relatively weak and often transient. Thus, novel strategies are necessary for enhancing immune responses induced by DNA immunization. Here, we demonstrated that co-immunization o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, So Young, Suh, You Suk, Cho, Jae Ho, Jin, Hyun Tak, Chang, Jun, Sung, Young Chul
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Immunologists 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816951/ https://www.ncbi.nlm.nih.gov/pubmed/20157605 http://dx.doi.org/10.4110/in.2009.9.5.169

Ejemplares similares

An antigenic epitope of influenza virus nucleoprotein (NP) associated with polymeric forms of NP
por: Prokudina, Elena N, et al.
Publicado: (2008)

Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice
por: Yin, Yuan, et al.
Publicado: (2020)

Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine
por: Powell, Timothy J., et al.
Publicado: (2013)

Eyedrop Vaccination Induced Systemic and Mucosal Immunity against Influenza Virus in Ferrets
por: Yoon, Sangchul, et al.
Publicado: (2016)

Role of influenza A virus NP acetylation on viral growth and replication
por: Giese, Sebastian, et al.
Publicado: (2017)

New vaccines against influenza virus
por: Lee, Young-Tae, et al.
Publicado: (2014)

Sublingual Immunization with M2-Based Vaccine Induces Broad Protective Immunity against Influenza
por: Shim, Byoung-Shik, et al.
Publicado: (2011)

AuNP-M2e + sCpG vaccination of juvenile mice generates lifelong protective immunity to influenza A virus infection
por: Bimler, Lynn, et al.
Publicado: (2019)

MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection
por: Gao, Feixia, et al.
Publicado: (2020)

Soluble Spike DNA Vaccine Provides Long-Term Protective Immunity against SARS-CoV-2 in Mice and Nonhuman Primates
por: Seo, Yong Bok, et al.
Publicado: (2021)

Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients
por: Kim, Tae Jin, et al.
Publicado: (2014)

Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts
por: Tutykhina, Irina, et al.
Publicado: (2018)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
por: McMahon, Meagan, et al.
Publicado: (2019)

Lactobacillus plantarum DK119 as a Probiotic Confers Protection against Influenza Virus by Modulating Innate Immunity
por: Park, Min-Kyung, et al.
Publicado: (2013)

ADJUVANTS IN IMMUNIZATION WITH INFLUENZA VIRUS VACCINES
por: Friedewald, William F.
Publicado: (1944)

Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1
por: Gwon, Yong-Dae, et al.
Publicado: (2016)

Assessment of mOMV adjuvant efficacy in the pathogenic H1N1 influenza virus vaccine
por: Lee, Byeong-Jae, et al.
Publicado: (2014)

Oral immunization of mice with recombinant rabies vaccine strain (ERAG3G) induces complete protection
por: Yang, Dong-Kun, et al.
Publicado: (2015)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
por: Asthagiri Arunkumar, Guha, et al.
Publicado: (2019)

Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
por: Wang, Wenling, et al.
Publicado: (2019)

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
por: Langenmayer, Martin C., et al.
Publicado: (2023)

CT findings in viral lower respiratory tract infections caused by parainfluenza virus, influenza virus and respiratory syncytial virus
por: Kim, Min-Chul, et al.
Publicado: (2016)

Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus
por: Kim, Ki-Hye, et al.
Publicado: (2018)

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans
por: Lillie, Patrick J., et al.
Publicado: (2012)

Nasal commensal Staphylococcus epidermidis enhances interferon-λ-dependent immunity against influenza virus
por: Kim, Hyun Jik, et al.
Publicado: (2019)

Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
por: Song, Jae-Min, et al.
Publicado: (2011)

Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection
por: Kang, Moon Cheol, et al.
Publicado: (2017)

The effect of PDT on H. influenzae biofilm in vivo
por: Rhee, Chung-Ku, et al.
Publicado: (2010)

Erratum: Plasmacytoid Dendritic Cells Contribute to the Protective Immunity Induced by Intranasal Treatment with Fc-fused Interleukin-7 against Lethal Influenza Virus Infection
por: Kang, Moon Cheol, et al.
Publicado: (2017)

Immune surveillance of nasopharyngeal carcinoma (NpC)
por: Oluwadara, Oluwadayo, et al.
Publicado: (2011)

Influenza vaccine coverage rates and perceptions on vaccination in South Korea
por: Kee, Sae Yoon, et al.
Publicado: (2007)

Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant
por: Choi, Hyo Jung, et al.
Publicado: (2015)

Potentiating the Cross-Reactive IFN-γ T Cell and Polyfunctional T Cell Responses by Heterologous GX-19N DNA Booster in Mice Primed with Either a COVID-19 mRNA Vaccine or Inactivated Vaccine
por: Seo, Yong Bok, et al.
Publicado: (2023)

Phospholipid scramblase 1 interacts with influenza A virus NP, impairing its nuclear import and thereby suppressing virus replication
por: Luo, Weiyu, et al.
Publicado: (2018)

Mechanisms of Cross-protection by Influenza Virus M2-based Vaccines
por: Lee, Yu-Na, et al.
Publicado: (2015)

Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection
por: Kim, So-Hee, et al.
Publicado: (2013)

Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP
por: Babin, Cindy, et al.
Publicado: (2013)

Inhibition of Influenza A Virus Replication by TRIM14 via Its Multifaceted Protein–Protein Interaction With NP
por: Wu, Xiangwei, et al.
Publicado: (2019)

Protective immunity by an engineered DNA vaccine for Mayaro virus
por: Choi, Hyeree, et al.
Publicado: (2019)

Co-Immunization of Plasmid DNA Encoding IL-12 and IL-18 with Bacillus Calmette-Guérin Vaccine against Progressive Tuberculosis
por: Jeon, Bo-Young, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g3p74eucpbaeu5ptbr6fssfo30